Here’s a look at three situations that look capable of producing good earnings growth this year – but there still looks to be value in the share price.
Gold broke through the US$3000 barrier for the first time ever, with gold in Australian dollars trading at $4,819.47 an ounce. For investors who want an exposure to gold, here are four ASX-listed gold exchange Traded Products (ETPs also known as ETFs). These four securities are the simplest and easiest ways to do so, simply using your stockbroking account.
Rare earth minerals are a crucial component of so many products that power our economy. Last Monday I looked at Australia’s two producers, Lynas Rare Earths and Iluka Resources. Today, I look at three companies best positioned to be our next producers, and I give you my choice of the three.
Rare earth minerals are a crucial component of so many products that power our economy. In the first of a two-part series, let’s first take a look at the state of play for two of Australia’s rare earths producers. Next week, I’ll look at which companies might become Australia’s – or the ASX’s – next rare earths producers.
While it has been a typical reporting season, there is a group of stocks where results were surprisingly good, but the market still appears to be under-valuing them. Here are three representatives from this group.
The mining heavyweights have been a lucrative source of fully franked dividends and while last week was something of a shock for investors who rely on the dividend flow from the big miners, they do still boast attractive expected dividend yields, though it’s getting harder to find value. Here’s how analysts see the trio of BHP, Fortescue and Rio Tinto, for now.
It made a massive splash last week, but is Sigma Healthcare worth buying?
The price of gold surged 34% last year and is already 9% higher this year, having notched a fresh record high of US$2,866.20 an ounce last month, making this a wonderful operating environment for gold miners. But investors have realised this, and most goldminers have been bid up by the share market to very full prices. But here are two ASX-listed miners where the analysts’ consensus price target implies that there’s still good value to be found.
Is there value in the S&P/ASX 20 right now? Here’s a look at four ‘buy’ prospects from the ASX’s top echelon: Telstra, Rio Tinto, BHP and CSL.
Here are two Australian medical device companies doing impressive things in the medical imaging area in Australia and the US.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.